| abstract |
The use, in combination, of purine, preferably adenosine, and non-steroidal anti-inflammatory drugs (NSAID), for example acetylsalicylic acid, salicylic acid, ibuprofen, naproxen, diclofenac, sulindac, celecoxib, rofecoxib or nabumetone, as active ingredients in the preparation of a drug to combat thromboses or restenosis induced after angioplasty |